Epigenetics Market by Product (Kits, Reagents, Enzymes, Instruments and Services) Technology (DNA Methylation, and Histone Modifications), Application (Oncology, Developmental Biology, Cardiovascular Diseases, Metabolic Diseases and Immunology) and Region - Analysis & Forecast 2019-2030
Report ID : 27 | Published Date : Feb 2019 | Pages : 150 | Region : global | Report Code : BT-7
Epigenetics Market Overview and Introduction
Epigenetics can be defined as the study of heritable changes which occur during the expression of genes, this changes do not led to alteration of underlying DNA sequences. It further involves the study of variations in physiological and cellular traits, in response to environmental or external stimuli. Alternations in epigenetics, leads to changes in the phenotype, whereas, the concerned genotype remains unaltered, i.e. constant. Changes in epigenetics are influenced by a broad range of factors, namely surrounding environment, age, disease state, lifestyle and others.
The global epigenetics market is driven by technological advancements in the genomics arena, increasing research expenditure in genetics, reduced price of DNA sequencing and incidences of cancer. However, high costs of epigenetic instruments is anticipated to somewhat restrict the lucrative growth of the epigenetics market during the forecast period.
Epigenetics Market by Product, Application and Technology
On the basis of product, the epigenetics market is segmented into kits, reagents, enzymes, instruments and services. The kits segment is further segmented into whole genomic amplification kit, RNA sequencing kit, chip sequencing kit, bisulfite conversion kit and others. Kits accounted for the largest share of the market owing to growing number of research on genetic and rising prevalence of several forms of diseases. Based on technology, the market is segmented into DNA methylation, histone modifications, and other technologies. The DNA methylation segment is estimated to account for the largest share of the global epigenetics market. The large share of this segment can be attributed to the technological advancement in DNA methylation techniques and PCR instrument. On the basis of application, the epigenetics market is segmented into oncology, developmental biology, cardiovascular diseases, metabolic diseases, immunology and other applications. The oncology segment is estimated to account for the largest share of the epigenetics market. Epigenetics is extensively used to derive strategies for oncology therapeutics to reverse the abnormalities in transcription.
Epigenetics Market by Regions
The global epigenetics market can be segmented into North America, Europe, Asia Pacific, and Rest of World (ROW). North America dominated the market of epigenetics, followed by Europe and Asia Pacific. North America will continue to dominate the global epigenetics market in the forecast period owing to factors such as highly developed R&D scenario and presence of private and public funding. However, Asia Pacific is expected to witness the highest CAGR, with the growth in this market centered at China, India, and Japan. Factors such as the rising focus of major players in emerging Asian countries and government support are driving the growth of the epigenetics market in this region.
Epigenetics Market Prominent Players
The prominent players in the global epigenetics market are Agilent Technologies, Thermo Fisher Scientific, Illumina, QIAGEN N.V., PerkinElmer, Merck KGaA, Abcam plc. , Active Motif, Bio-Rad Laboratories, Inc. , New England Biolabs and, Zymo Research among others.